1st Quarter - Report

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Signed letter from the Prevent Cancer Foundation to the House of Representatives and Senate supporting the Multi-Center Early Detection Screening Coverage Act Signed letter to House and Senate leadership urging, in the next COVID-19 relief package, Congress deploy resources to the Aging Network to help COVID-19 vaccination efforts targeting the most at-risk and the most difficult to reach older adults. Met with White House Domestic Policy Council to discuss ongoing support for adult vaccinations and infrastructure in the present and post-COVID.

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern Rep. Ed Perlmutter
MICHAEL WARD New —

Contacted: HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); Health & Human Services, Dept of (HHS); White House Office; SENATE; Food & Drug Administration (FDA)

Small Business SMB

Signed to the Acting Administrator of the US Small Business Administration requesting an investigation and rescission of federal Paycheck Protection Program funds that went to anti-vaccine organizations

LobbyistCovered position, as disclosed
MICHAEL WARD —

Contacted: Health & Human Services, Dept of (HHS); Small Business Administration (SBA); White House Office; Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Signed letter supporting the Administrations proposal to invest $450 billion in Medicaid home and community-based services Signed letter to Acting HHS Secretary urging the reinstatement of the Special Enrollment Period for Part D and Part D and the Equitable Relief for Premium Part A and Part B, requesting these COVID-19 related flexibilities remain in effect until December 31, 2021. Signed MAPRx letter to HHS Secretary urging a recission of a policy that would allow plans participating in the Center for Medicaid and Medicaid Innovation (CMMI) Part D Payment Modernization (PDM) Model to circumvent laws related to the six protected classes Signed Modern Medicaid Alliance letter urging House leadership to enhance federal financing for Medicaid by increasing states Federal Medical Assistance Percentage (FMAP) by a total of at least 12 percentage points Signed a Partnership for Part D Access letter to HHS Secretary urging a recission of a policy that would allow plans participating in the Center for Medicaid and Medicaid Innovation (CMMI) Part D Payment Modernization (PDM) Model to circumvent laws related to the six protected classes. Submitted letter to the Administration urging a recission of its proposed Most Favored Nations (MFN) proposed rule (CMS-5528-IFC) Met with staff in the House of Representatives and the Senate to advocate for an out-of-pocket cap in the Part D program and implement a smoothing mechanism to make cost-sharing payments more predictable.

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern Rep. Ed Perlmutter
MICHAEL WARD New —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; Small Business Administration (SBA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Signed letter to House and Senate Subcommittee on Labor, HHS, Education, and Related Agencies requested $10 million for the Administration for Community Living engagement of the aging services network to implement falls prevention programs and $4 million for the CDCs National Center for Injury Prevention and Control programming Signed letter to House and Senate Subcommittee on Labor, HHS, Education, and Related Agencies requesting $560 million for the Brain Research through Advancing Innovative Neurotechnology (BRAIN) Initiative Signed Friends of AHRQ letter to House and Senate Subcommittee on Labor, HHS, Education, and Related Agencies requesting $500 million for the Agency for Healthcare and Research and Quality (AHRQ) Signed letter to House and Senate leadership expressing support for the provision in the COVID relief reconciliation bill (section 3108) adopted by the House Energy and Commerce Committee to provide additional funding for Medicaid Home and Community Based Services

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern, Rep. Ed Perlmutter
MICHAEL WARD —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); White House Office; Small Business Administration (SBA); HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Signed letter to Acting HHS Secretary urging withdrawal of the proposed rule RE: Proposed Rule: Establishment of Safeguards and Program Integrity Requirements for Health and Human Services-Funded Extramural Research Involving Human Fetal Tissue (RIN 0991-AC15) Signed letter to Administration urging a recission of human fetal tissue research restrictions and policy changes that the Department of Health and Human Services made in 2019, specifically NOT-OD-19-128 and NOT-OD-19-137 Signed Leaders Engaged on Alzheimers Disease letter to FDA urging the agency to exercise regulatory flexibility in its review of aducanumab to treat Alzheimers disease. Participated in PDUFA VII stakeholder meeting with the FDA Participated in MDUFA V stakeholder meeting with the FDA

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern. Rep. Ed Perlmutter
MICHAEL WARD —

Contacted: Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA); Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.